Nexus Energy Services Inc (IBGR)

[vladimirr]

HPs Work Experiences:



2004 to Present

AQUANTUM, Inc. and Aquantum Pharmaceuticals, Inc.

President, CEO, and Owner Started these companies to continue product development and production systems design to manufacture a significantly improved solubilized aspirin/potassium pain reliever, (Xyprinol?) This product delivers 3 to 4 times the salicylate levels to the body than regular aspirin (for the same dose). The drug is totally absorbed into the body in less than 8 minutes. It is faster at reducting pain and inflammation than any other OTC pain reliever. It is also safer than any other OTC pain reliever on the market. Patents are being applied for.



2002 to 2006

Star Scientific Inc.

Mgr. Of Quality and Product Development Developed a tobacco tablet for cigarette smokers and moist snuff users. The tablets dissolved in the mouth over a predetermined time to deliver nicotine to the body. Oversaw production and continued to make improvements aand flavor changes to the product.







2000 to 2002

Pharmline Inc.

Florida, New York

VP of Operations Responsible for bringing the company?s technology into the ?state of the art? production capabilities. I was responsible for the redesign and construction of the present production facilities, the design and construction of a new manufacturing facility consisting of ?state of the art? fluid bed processing equipment. I designed and had manufactured for Pharmline the most advanced fluid bed processing equipment in the world. Several patents are obtainable for this equipment. I also reformulated most of their products into fluid bed processing, and formulated Nutritional Supplement products for other customers of Pharmline.



1993 to 1997

HEALTH, CORPORATION

Rocky Mount, North Carolina

President and owner Established a research and manufacturing company, which has developed AQUAPRIN, a potassium aspirin complex for which I have been awarded three patents. AQUAPRIN is a new soluble aspirin product, offering numerous advantages over existing commercial aspirin products now on the market. The company manufactures and packages the product, and has the capability of doing additional contract manufacturing. Personal investment exceeded $ 3 million. Product was sold through a national broker network to retail pharmacy chains, wholesalers, food and mass merchandisers. The company was located in a 60,000 sq. ft fully GMP facility on 22 acres of land in Rocky Mount, North Carolina, and could produce $30 million of product with its existing equipment and facility.



1984 to 1991,

GRANUTEC, INC.

Wilson, North Carolina

President and owner Established Granutec Inc. and constructed a 30,000 sq. ft. pharmaceutical plant in Wilson, NC. for development and production of pharmaceutical products and to develop fluid bed micro-encapsulation technology for use in the agriculture and pharmaceutical industries. Included in that process was the design and manufacture of continuous and batch pharmaceutical granulating equipment By the end of 1987, the company had expanded to 43,000 sq. ft. and in early 1988 purchased a 77,000 sq. ft. pharmaceutical packaging plant in Largo, Florida. Employees totaled over 230. The Largo facility was redesigned and reorganized and the two companies were sold in mid 1988 to Roussel Holdings Corporation, a division of Roussel UCLAF, owned by Hoechst. Sales of Granutec grew from $6 million in 1988 to over $40 million in 1990. In 1993, the company sales exceeded $60 million. The company does business with Wal-Mart, Eckerd, Perry Drug, Kerr Drug, Rite Aid, etc.



1981 to 1984

MATERIALS PROCESSING TECHNOLOGY INC.

Patterson, New Jersey

President and owner On April 1, 1981, I leased a new warehouse and by June 15, 1981, had a complete fluid bed based pharmaceutical plant built and operating, processing product for Monsanto, Warner-Lambert, Durkee Foods, McNeil (Johnson & Johnson), American Home Products, Rhone Poulenc and other major pharmaceutical companies. In January of 1983, Materials Processing Technology and PharmaControl merged and went public. I remained President of Materials Processing Technology and became COO of the public company.





1975 to 1981

GLATT AIR TECHNIQUES INC.

Ramsey, New Jersey

President Established American subsidiary of this European based company. Began with one secretary and myself for the purposes of introducing and selling fluid bed granulating and coating technology and equipment for the processing of pharmaceuticals, chemicals and foods. Ciba Geigy in Switzerland developed this technology. From 1975 to 1980, I built the company up to $12 million sales volume annually. Average profits were in excess of 30% net (before taxes) Expansion of the company and the need for more space propelled me to personally undertake the responsibility for the purchase of six acres of property and the design and construction of a new headquarters in Ramsey, New Jersey. In addition to the financial success of this company, contributions also include designing equipment totally new to the pharmaceutical industry. That equipment is still being used today successfully throughout the industry in such companies as Eli Lilly, John & Johnson (McNeil), Warner Lambert, Smith Kline.



1957 to 1975

TELEDYNE ISOTOPES

Westwood, New Jersey

Began my work experience with Teledyne as a nuclear engineer, and ended as International Marketing Manager and Director of Engineering. While with Teledyne, I developed many systems for detection of radioactivity. In 1959, I received his first patent for the development of a low-level beta ray detection system. In 1960, another employee and I took over a defaulting company to complete the construction and installation of low-level radiation detection Systems for the United States Health departments of many states. Teledyne Isotopes acquired several companies and I was put in charge of evaluation and the reorganization of the Engineering Departments for the companies. Was responsible for the program for developing a system for detection of underground nuclear test control during the Johnson Administration for the proposed underground Nuclear Test Ban Treaty. I designed the total detection system, including the electronics for the most advanced Carbon 14 dating systems in use. I became manager of Engineering and Development in 1964, and during the period from that time until my departure in July of 1975 received more than five additional patents for specialized detection systems

.

SUMMARY

In my dealings with major manufacturing companies, it is my experience that I have always been in the position of developing proprietary ways of manufacturing products and providing services which no one else in the industry could offer. Have always had a very good relationship with major manufacturers in the pharmaceutical industry because I have always supplied quality workmanship and have continuously been able to operate my facilities at capacity, staying at capacity even after expansion. In the areas of contract work, I have continued to maintain a level of confidence and a product which speaks for itself, and which the companies are willing to pay for. My relationship with Monsanto, Johnson & Johnson, Glaxo-SmithKline, Durkee Foods, Warner Lambert, Wyeth, and others will attest to that.



Education

Attended Columbia University

American Management Association and Professional development seminars in Management, FDA regulatory affairs, quality control, and manufacturing.











SUPPLEMENT

TO RESUME OF HOWARD PHYKITT



Pharmaceutical Formulation Experience:

In 1975, Mr. Phykitt started a subsidiary of a German Pharmaceutical equipment manufacturer , (Glatt GMBH) which had a license to Manufacture and sell fluid bed granulators, (a new process for processing raw materials into a granular, direct compressible form for tableting, which Ciba Geigy of Switzerland had developed and patented) This technology was becoming popular in Europe, but not accepted by the American pharmaceutical industry.



This company was started with only Phykitt and one secretary. A 5000 sq ft facility was leased in Norwood NJ where Phykitt built a research laboratory containing a small laboratory size fluid bed granulator. Traveling to all the major pharmaceutical companies and making presentations on the concept, Phykitt invited them to come to his laboratory with their present pharmaceutical formulations where Phykitt would reformulate them to be compatible with fluid bed technology. This usually meant a total change to all the inactive ingredients and binders. To be successful, we had to produce superior end product, easier to produce, more stable, and with better disintegration and dissolution characteristics. Phykitt's first success was with Eli Lilly and their product Darvoset-N, which was especially triumphant, since only three years earlier; Eli Lilly had researched the fluid bed process and rejected it as not being practical nor controllable. Sales in Glatt Air Techniques went from 0 to 12+ million dollars a year within the first five years. Today, fluid bed technology for granulating and coating is used by every major pharmaceutical manufacturer, and is by far the most widely accepted method of making pharmaceutical granulations for tablets.

Glatt GMBH of Germany and Glatt Air Techniques of America are the world leaders in pharmaceutical granulation equipment for making tablets. In six years at Glatt Air Techniques, Phykitt reformulated and set up the production equipment and production for the following products and companies



Eli Lilly Darvoset-N

Mc Neil Consumer Products (division Johnson & Johnson) Tylenol tablets (all sizes)

Tylenol capsules (all sizes)

Tylenol with Codeine (2-3-4)

Smith Kline Beecham Tagamet (tablet form)

Diazide

Contac (tablet form)

Relafen

Thorazine

Elavil

Zestril

Key Pharmaceuticals (Schering) Theo-Dur

K-[)ur

Hoffinan LaRoche Vitamin C granulation

Encapsulated vitarnin C

Shaklee Corporation Natural multi-vitamin tablet

and coating system

Durkee foods Microencapsulation process

for food ingredients

(patented with H Phykitt)

American Cynamid (Now Wyeth) Stresstabs

Monsanto Acetarninophen granulations





In 1978 while still at Glatt Air Techniques, Phykitt started a subsidiary company to do contract manufacturing utilizing the fluid bed process In 1981 Phykitt separated from Glatt, took the subsidiary company, (Materials Process Technology), and started a large scale manufacturing and research operation in Paterson, NJ. During the next few years, Materials Process Technology made granulations for companies such as, Monsanto, Warner Lambert, McNeil Consumer Products (Tylenol), Durkee Foods, Sylvania, Perrigo, and others. All these products required formulation work, and included development of new products, and changes in older formulations of well-known products. After going public with Pharmacontrol Inc., in 1983, the company licensed a soluble aspirin patent called Soluprin. Phykitt worked in the lab to improve this product with the incorporation of fluid bed drying. This product never was able to be made stable in scale-up, so it never went to market. In 1984, Phykitt left the company.



In 1985, Howard Phykitt started Granutec, Inc., a pharmaceutical company engaged in the business of private label manufacturing of over-the-counter analgesics, cough & cold products and allergy\decongestant products. Within 5 years, sales went from 0 to $ 40+ million dollars a year, employees increased from 3 to 240. The quick success of the company was in its ability to make generic copies of the major brand products with equal or better performance and quality. Every product had to be formulated from scratch, all of which was done in house by Phykitt and technicians who relied upon my direction. Phykitt sold the company in 1988, leaving in mid 1991.



Following is a partial list of private label (generic) products formulated by Phykitt personally at Granutec and that are currently being sold at stores like Wal-Mart, Eckerd Drug, Rite-Aid, etc.



Brand Name

Anacin III

Tylenol tablets and Gelcaps

Actifed

Sudafed

Anacin (aspirin and caffeine)

Bayer aspirin

Bayer aspirin Plus

Alka Seltzer

Advil (Ibuprofen)

Thera Flu

Excedrin (regular)

Bufferin and Tri Buffered aspirin

Ecotrin




From http://smarthunt.com/resume.cfm?portfolioid=35757

GLTA
Vlad
GO BMGI